Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 115001000168114 | Eligard 4 Month (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 115011000168112 | Eligard 4 Month | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eligard 4 Month | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eligard 4 Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe | Is a | True | Eligard 4 Month | Inferred relationship | Some | |
| Eligard 4 Month (inert substance) diluent, syringe | Is a | True | Eligard 4 Month | Inferred relationship | Some | |
| Eligard 4 Month (1 x 30 mg syringe, 1 x inert diluent syringe), 1 pack | has TP | True | Eligard 4 Month | Inferred relationship | Some | |
| Eligard 4 Month (1 x 30 mg syringe, 1 x inert diluent syringe), 1 pack | has TP | True | Eligard 4 Month | Inferred relationship | Some |
Reference Sets
FHIR